Chemoinformaics analysis of (8S)-2,6,6,11-TETRAMETHYLTRICYCLO[5.4.0.02,8]UNDEC-10-EN-9-OL
| Molecular Weight | 220.356 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 22 |
| Exact Molecular Weight | 220.183 | nRing | 4 |
| Solubility: LogS | -4.456 | nHRing | 0 |
| Solubility: LogP | 3.083 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.722 |
| Synth | 2.506 |
| Natural Product Likeliness | 0.553 |
| NR-PPAR-gamma | 0.155 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.067 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.835 |
| MDCK | 0.0000308 |
| BBB | 0.08 |
| PPB | 0.970523 |
| VDSS | 0.617 |
| FU | 0.0413171 |
| CYP1A2-inh | 0.929 |
| CYP1A2-sub | 0.79 |
| CYP2c19-inh | 0.89 |
| CYP2c19-sub | 0.256 |
| CYP2c9-inh | 0.778 |
| CYP2c9-sub | 0.842 |
| CYP2d6-inh | 0.744 |
| CYP2d6-sub | 0.851 |
| CYP3a4-inh | 0.889 |
| CYP3a4-sub | 0.245 |
| CL | 14.559 |
| T12 | 0.323 |
| hERG | 0.089 |
| Ames | 0.894 |
| ROA | 0.257 |
| SkinSen | 0.258 |
| Carcinogencity | 0.936 |
| EI | 0.073 |
| Respiratory | 0.905 |
| NR-Aromatase | 0.753 |
| Antiviral | Yes |
| Prediction | 0.912264 |